Individual Therapeutic Burden Profiling in Medication Management

Abstract

Individual therapeutic burden profiling is an emerging concept in optimizing medication management, particularly in the context of polypharmacy and complex multimorbidity. This review examines the scientific rationale, epidemiological trends, mechanistic underpinnings, and clinical implications of therapeutic burden profiling, emphasizing its relevance to personalized care and shared decision-making. Recent evidence highlights heterogeneity in therapeutic burden across patient populations, underscoring the need for individualized approaches to minimize adverse outcomes and enhance adherence. We discuss current diagnostic frameworks, risk stratification strategies, and advances in digital health tools, as well as guideline recommendations and future research directions.

Introduction

The landscape of medication management has evolved significantly with the increasing prevalence of chronic diseases and the resultant escalation in polypharmacy. Individual therapeutic burden, encompassing the cumulative impact of medication regimens on patient well-being, is now recognized as a crucial determinant of clinical outcomes. Profiling therapeutic burden involves a systematic evaluation of pharmacological, psychosocial, and logistical factors influencing a patient’s capacity to manage their medications effectively. This paradigm shift is driven by evidence linking excessive therapeutic burden to non-adherence, adverse drug events (ADEs), and diminished quality of life. Understanding and addressing individual therapeutic burden is paramount for healthcare professionals aiming to deliver patient-centered care in an era of personalized medicine.

Epidemiology / Disease Burden

Polypharmacy is highly prevalent among populations with multimorbidity, with studies indicating that up to 40% of adults over 65 in developed nations are prescribed five or more medications. The therapeutic burden is further compounded by non-pharmacological aspects such as regimen complexity, frequency of administration, monitoring requirements, and drug–drug or drug–disease interactions. Epidemiological data reveal that high therapeutic burden correlates with increased hospitalization rates, healthcare utilization, and mortality. The Global Burden of Disease Study emphasizes the rising tide of chronic illness, necessitating more nuanced approaches to medication management that account for the totality of patient experience rather than disease-specific protocols alone.

Pathophysiology

The pathophysiological consequences of excessive therapeutic burden are multifactorial. At the biological level, polypharmacy increases the risk of pharmacokinetic and pharmacodynamic interactions, leading to unpredictable drug responses and heightened susceptibility to ADEs. Cognitive overload from complex regimens can impair medication adherence, particularly in vulnerable populations such as the elderly or those with cognitive impairment. Additionally, psychological stress associated with managing multiple therapies can exacerbate underlying conditions, creating a vicious cycle of treatment escalation and diminishing returns. Mechanism-based profiling enables clinicians to anticipate and mitigate these risks by tailoring interventions to the individual’s physiological reserve and psychosocial context.

Risk Factors

Key risk factors for elevated therapeutic burden include advanced age, multimorbidity, polypharmacy, cognitive dysfunction, low health literacy, and limited social support. Socioeconomic disparities, fragmented care delivery, and inadequate medication reconciliation further contribute to the risk profile. In particular, transitions of care such as hospital discharge are critical junctures where lapses in communication can lead to increased therapeutic burden and downstream adverse events. Recognizing these risk factors is essential for early identification of at-risk individuals and prioritizing interventions that reduce unnecessary complexity.

Clinical Features

Patients experiencing high therapeutic burden may present with non-specific symptoms such as fatigue, confusion, falls, gastrointestinal complaints, or unexplained functional decline. More specific indicators include frequent missed doses, medication errors, or requests for regimen simplification. Clinicians should adopt a proactive approach to eliciting medication-related distress, as patients often underreport these concerns. Standardized assessment tools such as the Medication Regimen Complexity Index (MRCI) and patient-reported outcome measures (PROMs) can aid in quantifying and tracking therapeutic burden over time.

Diagnosis

Diagnosing excessive therapeutic burden requires a holistic evaluation encompassing pharmacological review, patient interview, and assessment of medication management capacity. Comprehensive medication reconciliation, coupled with structured profiling tools, enables identification of unnecessary or redundant therapies, potential interactions, and barriers to adherence. Shared decision-making is integral to this process, ensuring that individual preferences and goals of care inform regimen optimization. Digital health platforms and electronic health records (EHRs) increasingly facilitate real-time burden assessment and multidisciplinary collaboration.

Treatment & Management

Effective management of therapeutic burden involves both reduction of unnecessary pharmacotherapy and optimization of essential regimens. Deprescribing protocols, guided by evidence-based algorithms and clinical judgment, play a central role. Simplification strategies include once-daily dosing, fixed-dose combinations, and synchronization of refill schedules. Patient education and empowerment are critical for sustaining adherence and self-management. Multidisciplinary care models incorporating pharmacists, nurses, and case managers demonstrate improved outcomes in high-burden populations by coordinating care and addressing non-pharmacological determinants of burden.

Recent Advances / Emerging Therapies

Technological innovation has catalyzed advances in therapeutic burden profiling. Digital adherence monitoring, mobile health applications, and artificial intelligence-driven risk prediction support dynamic and individualized intervention. Pharmacogenomics and precision medicine approaches offer the potential to further personalize regimens by predicting drug response and minimizing adverse effects. Emerging research supports the integration of patient-reported outcome data into clinical workflows to continuously adapt therapy intensity. Furthermore, health system initiatives targeting deprescribing and regimen simplification are gaining traction, with preliminary evidence supporting reductions in ADEs and healthcare costs.

Guideline Recommendations

Major clinical guidelines now emphasize the importance of individualized therapeutic burden assessment and management. The American Geriatrics Society, National Institute for Health and Care Excellence (NICE), and World Health Organization advocate for regular medication reviews, shared decision-making, and prioritization of patient preferences. Specific recommendations include routine use of structured complexity indices, proactive identification of high-risk patients, and incorporation of burden minimization into chronic disease management pathways. Ongoing professional education and system-level support are essential for translating these recommendations into clinical practice.

Conclusion

Individual therapeutic burden profiling represents a paradigm shift in medication management, aligning with principles of personalized and patient-centered care. By systematically evaluating and addressing the total burden of therapy, clinicians can reduce adverse outcomes, enhance quality of life, and optimize resource utilization. Continued research, interdisciplinary collaboration, and technological integration are necessary to refine burden assessment tools and implement scalable interventions. As healthcare systems evolve, embedding therapeutic burden profiling within routine practice will be integral to achieving safer and more effective medication management for complex patient populations.